Evidence map›Paper›PMID 31410611›Full record

ArticleMolecular genetics and genomics : MGG2020

Identification of rs11615992 as a novel regulatory SNP for human P2RX7 by allele-specific expression.

Tao Peng, Li Zhong, Jing Gao, Zhu Wan, Wei-Ping Fu, Chang Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Functional Variants Associated WithFrontiers in genetics · 2022
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tao Peng *National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, People's Republic of China.
Li Zhong *National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, People's Republic of China.
Jing GaoNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, People's Republic of China.
Zhu WanDepartment of Respiratory Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.
Wei-Ping FuDepartment of Respiratory Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China. fuweiping2@163.com.
Chang SunNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, People's Republic of China. sunchang@snnu.edu.cn.ORCID http://orcid.org/0000-0002-2425-9485
Shaanxi Normal University · CNKunming Medical University · CN

Funding

Fundamental Research Funds for the Central Universities GK201701005Fundamental Research Funds for the Central Universities GK201703031High level talent training program in Yunnan D-201662Joint project of Yunnan Provincial Science and Technology Department and Kunming Medical University 2017FE467-030
6 · The paper itself

Abstract

P2RX7 (purinergic receptor P2X 7) is an important membrane ion channel and involved in multiple physiological processes. One non-synonymous SNP on P2RX7, rs3751143, had been proven to reduce ion channel function and further associated with multiple diseases. However, it was still unclear whether there were other cis-regulatory elements for P2RX7, which might further contribute to related diseases. Allele-specific expression (ASE) is a robust and sensitive approach to identify the potential functional region in human genome. In the current study, we measured ASE on rs3751143 in lung tissues and observed a consistent excess of A allele over C (P = 0.001), which indicated that SNP(s) in linkage disequilibrium (LD) could regulate P2RX7 expression. By analyzing the 1000 genomes project data for Chinese, one SNP locating ~ 5 kb away and downstream of P2RX7, rs11615992, was disclosed to be in strong LD with rs3751143. The dual-luciferase assay confirmed that rs11615992 could alter target gene expression in lung cell line. Through chromosome conformation capture, it was verified that the region surrounding rs11615992 could interact with P2RX7 promoter and effect as an enhancer. By chromatin immunoprecipitation, the related transcription factor POU2F1 (POU class 2 homeobox 1) was recognized to bind the region spanning rs11615992. Our work identified a novel long-distance cis-regulatory SNP for P2RX7, which might contribute to multiple diseases.

Indexed as

AllelesGene FrequencyGenetic Predisposition to DiseaseGenome, HumanHaplotypesHumansLinkage DisequilibriumPolymorphism, Single NucleotidePromoter Regions, GeneticReceptors, Purinergic P2X7P2RX7 protein, humanReceptors, Purinergic P2X7Allele-specific expression (ASE)EnhancerExpression regulationP2RX7rs11615992rs3751143

Identifiers

PMID31410611
OpenAlexW2967576741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.